nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—ABCB1—peripheral nervous system neoplasm	0.215	1	CbGaD
Selegiline—L-Phenylalanine—Melphalan—peripheral nervous system neoplasm	0.193	1	CrCrCtD
Selegiline—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.055	0.137	CbGbCtD
Selegiline—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0358	0.0893	CbGbCtD
Selegiline—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0312	0.0778	CbGbCtD
Selegiline—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0271	0.0676	CbGbCtD
Selegiline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0226	0.0563	CbGbCtD
Selegiline—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0197	0.0492	CbGbCtD
Selegiline—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0197	0.0492	CbGbCtD
Selegiline—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0189	0.0472	CbGbCtD
Selegiline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0181	0.045	CbGbCtD
Selegiline—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0153	0.0382	CbGbCtD
Selegiline—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0153	0.0381	CbGbCtD
Selegiline—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0137	0.0341	CbGbCtD
Selegiline—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0118	0.0295	CbGbCtD
Selegiline—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0114	0.0285	CbGbCtD
Selegiline—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.011	0.0274	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0103	0.0256	CbGbCtD
Selegiline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00883	0.022	CbGbCtD
Selegiline—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00843	0.021	CbGbCtD
Selegiline—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0081	0.0202	CbGbCtD
Selegiline—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00786	0.0196	CbGbCtD
Selegiline—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00773	0.0193	CbGbCtD
Selegiline—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00527	0.0131	CbGbCtD
Selegiline—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00505	0.0126	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00496	0.0124	CbGbCtD
Selegiline—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00463	0.0115	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00316	0.00787	CbGbCtD
Selegiline—L-Phenylalanine—TH—peripheral nervous system neoplasm	0.00103	0.644	CrCbGaD
Selegiline—Ephedrine—BCHE—peripheral nervous system neoplasm	0.000569	0.356	CrCbGaD
Selegiline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000269	CcSEcCtD
Selegiline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	5.09e-05	0.000269	CcSEcCtD
Selegiline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	5.08e-05	0.000268	CcSEcCtD
Selegiline—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000267	CcSEcCtD
Selegiline—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000266	CcSEcCtD
Selegiline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.04e-05	0.000266	CcSEcCtD
Selegiline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.03e-05	0.000265	CcSEcCtD
Selegiline—Weight increased—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000265	CcSEcCtD
Selegiline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000264	CcSEcCtD
Selegiline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	4.99e-05	0.000264	CcSEcCtD
Selegiline—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000263	CcSEcCtD
Selegiline—Somnolence—Etoposide—peripheral nervous system neoplasm	4.98e-05	0.000263	CcSEcCtD
Selegiline—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000263	CcSEcCtD
Selegiline—Asthenia—Vincristine—peripheral nervous system neoplasm	4.96e-05	0.000262	CcSEcCtD
Selegiline—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000261	CcSEcCtD
Selegiline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.00026	CcSEcCtD
Selegiline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.92e-05	0.00026	CcSEcCtD
Selegiline—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000259	CcSEcCtD
Selegiline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.91e-05	0.000259	CcSEcCtD
Selegiline—Rash—Dactinomycin—peripheral nervous system neoplasm	4.88e-05	0.000258	CcSEcCtD
Selegiline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.87e-05	0.000257	CcSEcCtD
Selegiline—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.84e-05	0.000255	CcSEcCtD
Selegiline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.83e-05	0.000255	CcSEcCtD
Selegiline—Fatigue—Etoposide—peripheral nervous system neoplasm	4.83e-05	0.000255	CcSEcCtD
Selegiline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000255	CcSEcCtD
Selegiline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000253	CcSEcCtD
Selegiline—Pain—Etoposide—peripheral nervous system neoplasm	4.79e-05	0.000253	CcSEcCtD
Selegiline—Constipation—Etoposide—peripheral nervous system neoplasm	4.79e-05	0.000253	CcSEcCtD
Selegiline—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000253	CcSEcCtD
Selegiline—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000253	CcSEcCtD
Selegiline—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000252	CcSEcCtD
Selegiline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.74e-05	0.00025	CcSEcCtD
Selegiline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.73e-05	0.00025	CcSEcCtD
Selegiline—Sweating—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000249	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000249	CcSEcCtD
Selegiline—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000248	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000246	CcSEcCtD
Selegiline—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000246	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000245	CcSEcCtD
Selegiline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000245	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000244	CcSEcCtD
Selegiline—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000244	CcSEcCtD
Selegiline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.62e-05	0.000244	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000243	CcSEcCtD
Selegiline—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.6e-05	0.000243	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000242	CcSEcCtD
Selegiline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.58e-05	0.000242	CcSEcCtD
Selegiline—Dizziness—Vincristine—peripheral nervous system neoplasm	4.57e-05	0.000241	CcSEcCtD
Selegiline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.56e-05	0.000241	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.00024	CcSEcCtD
Selegiline—Rash—Alitretinoin—peripheral nervous system neoplasm	4.52e-05	0.000239	CcSEcCtD
Selegiline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.52e-05	0.000239	CcSEcCtD
Selegiline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.5e-05	0.000238	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000237	CcSEcCtD
Selegiline—Headache—Alitretinoin—peripheral nervous system neoplasm	4.49e-05	0.000237	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000236	CcSEcCtD
Selegiline—Urticaria—Etoposide—peripheral nervous system neoplasm	4.45e-05	0.000235	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000234	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000234	CcSEcCtD
Selegiline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.43e-05	0.000234	CcSEcCtD
Selegiline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.43e-05	0.000234	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000234	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000234	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.000233	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000232	CcSEcCtD
Selegiline—Vomiting—Vincristine—peripheral nervous system neoplasm	4.4e-05	0.000232	CcSEcCtD
Selegiline—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.39e-05	0.000232	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000232	CcSEcCtD
Selegiline—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000231	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.00023	CcSEcCtD
Selegiline—Rash—Vincristine—peripheral nervous system neoplasm	4.36e-05	0.00023	CcSEcCtD
Selegiline—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.36e-05	0.00023	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.00023	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000229	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000229	CcSEcCtD
Selegiline—Headache—Vincristine—peripheral nervous system neoplasm	4.33e-05	0.000229	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000227	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000227	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000226	CcSEcCtD
Selegiline—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.26e-05	0.000225	CcSEcCtD
Selegiline—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000225	CcSEcCtD
Selegiline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.18e-05	0.000221	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.00022	CcSEcCtD
Selegiline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.13e-05	0.000218	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000217	CcSEcCtD
Selegiline—Nausea—Vincristine—peripheral nervous system neoplasm	4.11e-05	0.000217	CcSEcCtD
Selegiline—Flushing—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.000216	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000216	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000216	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000215	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000214	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000213	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000213	CcSEcCtD
Selegiline—Asthenia—Etoposide—peripheral nervous system neoplasm	4.02e-05	0.000212	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000212	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000212	CcSEcCtD
Selegiline—Chills—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000209	CcSEcCtD
Selegiline—Pruritus—Etoposide—peripheral nervous system neoplasm	3.96e-05	0.000209	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000208	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000208	CcSEcCtD
Selegiline—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000206	CcSEcCtD
Selegiline—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.89e-05	0.000205	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000204	CcSEcCtD
Selegiline—Rash—Cisplatin—peripheral nervous system neoplasm	3.85e-05	0.000203	CcSEcCtD
Selegiline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.85e-05	0.000203	CcSEcCtD
Selegiline—Erythema—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000203	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000203	CcSEcCtD
Selegiline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.83e-05	0.000202	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000201	CcSEcCtD
Selegiline—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.0002	CcSEcCtD
Selegiline—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.0002	CcSEcCtD
Selegiline—Tension—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000199	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000199	CcSEcCtD
Selegiline—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000197	CcSEcCtD
Selegiline—Back pain—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000196	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000196	CcSEcCtD
Selegiline—Dizziness—Etoposide—peripheral nervous system neoplasm	3.7e-05	0.000196	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000195	CcSEcCtD
Selegiline—Chills—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000194	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000193	CcSEcCtD
Selegiline—Nausea—Cisplatin—peripheral nervous system neoplasm	3.63e-05	0.000192	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000191	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000191	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000189	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000188	CcSEcCtD
Selegiline—Vomiting—Etoposide—peripheral nervous system neoplasm	3.56e-05	0.000188	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000188	CcSEcCtD
Selegiline—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000188	CcSEcCtD
Selegiline—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000188	CcSEcCtD
Selegiline—Agitation—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000187	CcSEcCtD
Selegiline—Rash—Etoposide—peripheral nervous system neoplasm	3.53e-05	0.000186	CcSEcCtD
Selegiline—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.53e-05	0.000186	CcSEcCtD
Selegiline—Headache—Etoposide—peripheral nervous system neoplasm	3.51e-05	0.000185	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000185	CcSEcCtD
Selegiline—Tension—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000184	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000184	CcSEcCtD
Selegiline—Malaise—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000183	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000182	CcSEcCtD
Selegiline—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000182	CcSEcCtD
Selegiline—Syncope—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000182	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000182	CcSEcCtD
Selegiline—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000182	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000181	CcSEcCtD
Selegiline—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000179	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000178	CcSEcCtD
Selegiline—Cough—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000177	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000177	CcSEcCtD
Selegiline—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000176	CcSEcCtD
Selegiline—Nausea—Etoposide—peripheral nervous system neoplasm	3.33e-05	0.000176	CcSEcCtD
Selegiline—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000175	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000174	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000174	CcSEcCtD
Selegiline—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000173	CcSEcCtD
Selegiline—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000173	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000173	CcSEcCtD
Selegiline—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000173	CcSEcCtD
Selegiline—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000172	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000172	CcSEcCtD
Selegiline—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000171	CcSEcCtD
Selegiline—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000169	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000169	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000169	CcSEcCtD
Selegiline—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000169	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000168	CcSEcCtD
Selegiline—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000167	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000166	CcSEcCtD
Selegiline—Oedema—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000166	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000165	CcSEcCtD
Selegiline—Infection—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000165	CcSEcCtD
Selegiline—Cough—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000164	CcSEcCtD
Selegiline—Shock—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000163	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000163	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000163	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000162	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000162	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000162	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000161	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.00016	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.00016	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.00016	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.00016	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000159	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000159	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000158	CcSEcCtD
Selegiline—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000158	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000156	CcSEcCtD
Selegiline—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000155	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000155	CcSEcCtD
Selegiline—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000153	CcSEcCtD
Selegiline—Infection—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000152	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000151	CcSEcCtD
Selegiline—Shock—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000151	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.00015	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.00015	CcSEcCtD
Selegiline—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.00015	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.00015	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000149	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000149	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000148	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000148	CcSEcCtD
Selegiline—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000147	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000146	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.76e-05	0.000146	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000144	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000143	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000143	CcSEcCtD
Selegiline—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000143	CcSEcCtD
Selegiline—Pain—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000142	CcSEcCtD
Selegiline—Constipation—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000142	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.00014	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000139	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000138	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000137	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000137	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000136	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000136	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000135	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000133	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000132	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000132	CcSEcCtD
Selegiline—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.49e-05	0.000132	CcSEcCtD
Selegiline—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000131	CcSEcCtD
Selegiline—Pain—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000131	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.48e-05	0.000131	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.48e-05	0.000131	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000126	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.000125	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000122	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000122	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000121	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000121	CcSEcCtD
Selegiline—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.000119	CcSEcCtD
Selegiline—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.22e-05	0.000117	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.15e-05	0.000113	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000113	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.00011	CcSEcCtD
Selegiline—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.00011	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	0.000108	CcSEcCtD
Selegiline—Vomiting—Epirubicin—peripheral nervous system neoplasm	2e-05	0.000105	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.99e-05	0.000105	CcSEcCtD
Selegiline—Rash—Epirubicin—peripheral nervous system neoplasm	1.98e-05	0.000104	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.98e-05	0.000104	CcSEcCtD
Selegiline—Headache—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.000104	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	0.000101	CcSEcCtD
Selegiline—Nausea—Epirubicin—peripheral nervous system neoplasm	1.86e-05	9.84e-05	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.85e-05	9.75e-05	CcSEcCtD
Selegiline—Rash—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	9.67e-05	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	9.66e-05	CcSEcCtD
Selegiline—Headache—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	9.61e-05	CcSEcCtD
Selegiline—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	9.11e-05	CcSEcCtD
